COST-UTILITY ANALYSIS OF DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE IN PANAMA

被引：0
|
作者：
Ordonez, J. [1 ]
Valdes, R. [2 ]
Courville, K. [2 ]
Perez, R. [2 ]
Ordonez, A. [3 ]
Hidalgo Godinez, J. [4 ]
Villalobos, K. [4 ]
机构：
[1] True Consulting, Medellin, Colombia
[2] Caja Seguridad Social Panama, Panama City, Panama
[3] True Consulting, Medellin, Colombia
[4] AstraZeneca CAC, San Jose, Costa Rica
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HTA5
引用
收藏
页码：S504 / S505
页数：2
相关论文
共 50 条
  • [21] Cost-effectiveness analysis of dapagliflozin for people with chronic kidney disease in Malaysia
    Lim, Soo Kun
    Lee, Shaun Wen Huey
    PLOS ONE, 2024, 19 (03):
  • [22] Cost-utility analysis and eligibility of dapagliflozin for patients with heart failure across the whole spectrum of ejection fraction
    Kim, E. S.
    Park, S. K.
    Youn, J. C.
    Lee, H. Y.
    Kim, M. S.
    Choi, J. O.
    Kang, S. M.
    Yoo, B. S.
    Choi, D. J.
    Oh, B. H.
    Baek, S. H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 197 - 197
  • [23] Cost-utility analysis
    Brown, GC
    Brown, MM
    Sharma, S
    ANNALS OF INTERNAL MEDICINE, 2001, 134 (07) : 625 - 626
  • [24] COST-UTILITY ANALYSIS
    NICHOLLS, A
    BRITISH MEDICAL JOURNAL, 1993, 307 (6913): : 1213 - 1213
  • [25] Telemonitoring for chronic obstructive pulmonary disease: a cost and cost-utility analysis of a randomised controlled trial
    Stoddart, Andrew
    van der Pol, Marjon
    Pinnock, Hilary
    Hanley, Janet
    McCloughan, Lucy
    Todd, Allison
    Krishan, Ashma
    McKinstry, Brian
    JOURNAL OF TELEMEDICINE AND TELECARE, 2015, 21 (02) : 108 - 118
  • [26] Cost-Utility Analysis of Dapagliflozin as an Add-On to Standard Treatment for Patients with Type 2 Diabetes and High Risk of Cardiovascular Disease in Thailand
    Deerochanawong, Chaicharn
    Vareesangthip, Kriengsak
    Piyayotai, Dilok
    Thongsuk, Dittaya
    Pojchaijongdee, Nuch
    Permsuwan, Unchalee
    DIABETES THERAPY, 2021, 12 (07) : 1947 - 1963
  • [27] COST-UTILITY ANALYSIS OF HOME TELEMONITORING IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE
    Stafylas, P.
    Dafoulas, G.
    Aletras, V. H.
    Lashos, V
    Raptis, O.
    VALUE IN HEALTH, 2008, 11 (06) : A397 - A397
  • [28] Cost-Effectiveness of Dapagliflozin for Chronic Kidney Disease in Japan
    Kodera, Satoshi
    Morita, Hiroyuki
    Nishi, Hiroshi
    Takeda, Norifumi
    Ando, Jiro
    Komuro, Issei
    CIRCULATION JOURNAL, 2022, 86 (12) : 2021 - +
  • [29] Cost-utility of a disease management program for patients with asthma
    Steuten, Lotte
    Palmer, Stephen
    Vrijhoef, Bert
    van Merode, Frits
    Spreeuwenberg, Cor
    Severens, Hans
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2007, 23 (02) : 184 - 191
  • [30] A synthesis of cost-utility analysis literature in infectious disease
    Stone, PW
    Schackman, BR
    Neukermans, CP
    Olchanski, N
    Greenberg, D
    Rosen, AB
    Neumann, PJ
    LANCET INFECTIOUS DISEASES, 2005, 5 (06): : 383 - 391
12345